Mackenzie Financial Corp Cyclerion Therapeutics, Inc. Transaction History

Mackenzie Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.42 - $18.8 $911 - $40,796	2,170 Added 7.94%	29,490 $19,000
Q3 2022 Oct 07, 2022	SELL	$0.58 - $18.2 $7,887 - $247,520	-13,600 Reduced 33.24%	27,320 $23,000
Q2 2022 Aug 10, 2022	BUY	$0.47 - $1.29 $7,337 - $20,138	15,611 Added 61.68%	40,920 $22,000
Q1 2022 May 13, 2022	BUY	$0.96 - $1.78 $24,296 - $45,050	25,309 New	25,309 $28,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $139M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.